Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury
dc.authorid | 0000-0002-1706-4444 | en_US |
dc.authorid | 0000-0002-4060-3354 | en_US |
dc.authorid | 0000-0003-2696-8274 | |
dc.authorid | 0000-0001-7965-6229 | |
dc.contributor.author | Gideroğlu, Kaan | |
dc.contributor.author | Yılmaz, Fahrettin | |
dc.contributor.author | Aksoy, Fadullah | |
dc.contributor.author | Buğdaycı, Güler | |
dc.contributor.author | Sağlam, İbrahim | |
dc.contributor.author | Yılmaz, Fahri | |
dc.date.accessioned | 2021-06-23T19:26:03Z | |
dc.date.available | 2021-06-23T19:26:03Z | |
dc.date.issued | 2009 | |
dc.department | BAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | |
dc.description.abstract | Background. Recent studies have shown that neutrophils play an important role in the pathogenesis of reperfusion injury. Using an inferior epigastric artery skin flap as a flap ischemia/reperfusion (I/R) injury model, we investigated whether the administration of montelukast sodium, a selective reversible cysteinyl leukotriene 1 (Cy5LT1) receptor antagonist, decreases neutrophil infiltration and promotes flap survival. Methods. Eighteen rats were used and randomly divided into three groups (n = 6 for each group). Group I was the sham group and did not undergo ischemic insult; rather, normal saline (1mL) was administrated intraperitonealy (i.p.) 30 min before surgery and continued for 6 d. Group II (control) and Group III (montelukast) underwent 12 h of ischemic insult. For Group II, normal saline (1mL) was injected i.p. 30 min before the surgery and immediately before reperfusion, and this continued for 6 d. In Group III, 1mL of montelukast (10mg/kg) was injected i.p. and continued for 6 d. Malondialdehyde (MDA) and glutathione (GSH) levels and myeloperoxidase (MPO) enzyme activities were investigated. Histological evaluation was made to investigate the tissue neutrophil count. Survival areas were assessed at 7 d postoperatively. Results. Group III (montelukast- treated) showed a significantly higher survival rate than Group II (control) (P = 0.029) but a lower survival rate than Group I (sham). Histological and biochemical assays corroborated this data. Conclusion. This study suggests that montelukast CysLT1 receptor antagonist montelukast reversed I/R-induced oxidant responses and improved flap survival by inhibiting neutrophil infiltration and balancing oxidant and antioxidant status. (C) 2009 Elsevier Inc. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/j.jss.2008.07.031 | |
dc.identifier.endpage | 186 | en_US |
dc.identifier.issn | 0022-4804 | |
dc.identifier.issn | 1095-8673 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 19589545 | en_US |
dc.identifier.scopus | 2-s2.0-70450238022 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 181 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jss.2008.07.031 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/6393 | |
dc.identifier.volume | 157 | en_US |
dc.identifier.wos | WOS:000276650200008 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Gideroğlu, Kaan | |
dc.institutionauthor | Yılmaz, Fahrettin | |
dc.institutionauthor | Buğdaycı, Güler | |
dc.institutionauthor | Sağlam, İbrahim | |
dc.institutionauthor | Yılmaz, Fahri | |
dc.language.iso | en | en_US |
dc.publisher | Academic Press Inc Elsevier Science | en_US |
dc.relation.ispartof | Journal Of Surgical Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Montelukast | en_US |
dc.subject | Ischemia Reperfusion | en_US |
dc.subject | Injury | en_US |
dc.subject | Axial Pattern Skin Flap | en_US |
dc.title | Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- kaan-gideroglu.pdf
- Boyut:
- 610.15 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam metin/Full text